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Abstract 
Background Cervical spondylotic myelopathy (CSM) is typically encountered in the elderly 
population.  Significant inconsistencies currently exist regarding the definition of the disorder, 
the true incidence of CSM in younger populations, and the established diagnostic criteria.   
Objective To highlight the lack of standardization in the definition and diagnosis of CSM. 
Methods A PubMed literature search was conducted spanning the years 2001 to 2011.  The 
search was limited by the following terms: 1) English language, 2) Adults (19-44 years old), and 
3) “cervical spondylotic myelopathy.”  Each article was reviewed to determine if the presence of 
the definition of CSM existed in the article.  The clinical characteristics used to make the 
diagnosis of CSM were recorded for each article.  Cochran’s Q statistic was used to determine 
whether some clinical characteristics were more frequently used than others. 
Results 93 papers were reviewed in detail and 16 case reports, reviews, and articles 
concerning less than three patients were excluded, resulting in 77 articles in the final analysis. 
The most common clinical definitions were gait disturbance (22/77 articles (28.6%)), upper limb 
paresthesias or sensory disturbance (21/77 (27.3%)), and clumsy hands (15/77 (19.5%)). 
Hyperreflexia, spasticity, and pathologically increased reflexes were identified as diagnostic 
criteria in a minority of patients.  
Conclusion The literature employs a wide range of neurologic signs and symptoms to make 
the diagnosis of CSM, with a majority of studies failing to rely on strict diagnostic criteria.  The 
clinician should not discount CSM as an explanation for the aforementioned findings, as it is 
well-reported in the literature among the ages 18-44.  
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Introduction 
Cervical spondylotic myelopathy (CSM), the most common disorder of the spinal cord in 
persons older than 55 years of age, remains a challenging pathology to manage in modern 
neurosurgical practice.[1]  As the mean age of the population continues to rise, it can be expected 
that an increasingly frequent number of patients will present with the signs and symptoms of 
CSM.  However, among patients with CSM, there is considerable variability in both the clinical 
presentation and imaging findings(Figure 1-4).[2]  The temporal evolution of symptoms covers a 
wide range, spanning from acute to chronic progression and neurologic deterioration.[3-5], the 
optimal management strategy must be tailored to each individual patient and multiple surgical 
approaches are routinely utilized.[6-9]  Despite the high frequency with which CSM is 
encountered in clinical practice, the diagnostic criteria continues to suffer from a significant lack 
of uniformity. 
The diagnosis of CSM is primarily based on the clinical signs found on physical 
examination and is supported by imaging findings of cervical spondylosis with cord 
compression.[2]   Numerous authors have addressed the defining clinical characteristics and 
diagnostic criteria, however, a careful analysis of the literature reveals multiple inconsistencies.  
The underlying discrepancies are multifactorial in nature, stemming from the complexity of the 
disease and the vast number of treatment options currently available.  Additionally, the existing 
literature emanates from diverse specialties, including, neurology, neurosurgery, internal 
medicine, and rehabilitation medicine.  Practitioners from different specialties encounter patients 
of varying acuity of symptom onset, thereby contributing to the multiple approaches to 
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treatment.  As a result, the comparison of data across studies, such as, indications for surgery, 
complications, and treatment efficacy is of limited utility.   
Utilizing the PubMed search engine, the literature over the last ten years (2001 – 2011) 
pertaining to the clinical presentation, diagnosis, and surgical management of CSM were 
reviewed.  Specifically, articles were reviewed to determine if CSM was explicitly defined, to 
pin point the diagnosticcriteria used, and to identify discrepancies and inconsistencies between 
manuscripts.  Additionally, we also present a review of the presenting findings in the literature of 
younger patient populations affected with CSM (ages 19-44).  
Methods 
 Using the PubMed search engine, a search was conducted spanning the years 2001 to 
2011.  The search specifically focused on the following limiting terms: 1) English language, 2) 
Adults (19-44 years old), and 3) “cervical spondylotic myelopathy.”  Each article was 
individually reviewed and analyzed to determine if the authors explicitly defined CSM within the 
manuscript.  The clinical characteristics used to make the diagnosis of CSM were recorded for 
each article as follows: gait disturbance, lack of coordination, clumsy hands, paresis, spasticity, 
hyperreflexia, hyporeflexia, sensory disturbance, pattern of weakness, Lhermitte’s sign, 
Romberg’s sign, Hoffman’s sign, Babinski’s sign, and bowel or bladder dysfunction.   
 Cochran’s Q statistic was used to determine whether some clinical characteristics were 
more frequently used than others. Cochran’s test allows analysis of data where the same item 
occurs in more than one category.  A critical range was calculated to indicate which 
characteristics were selected at significant rates.[10] 
Results 
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 93 articles meeting the search criteria were identified.  16 case reports, reviews, and 
articles concerning less than three patients were excluded, resulting in the inclusion of 77 articles 
in the present study. The breakdown of the signs and symptoms are presented in Table 1 (Table 
1).   Cochran’s Q statistic indicated that the rates were significantly different, with a critical 
range of 16.37%.   
Gait disturbance, cited in 22 (28.57%) of the papers reviewed, was the most common 
sign or symptom found in patients diagnosed with CSM.  Reported in 21 (27.27%) of the papers, 
loss of sensation in the upper extremities was the second most common finding. The critical 
range of the Cochran Q test was 16.37%.  Gait disturbances were therefore significantly more 
frequently used in CSM diagnoses than lower limb weakness (28.57% - 11.69% > 16.37%) or 
any of the less frequently used criteria.  Similarly, upper limb paresthesia or sensory disturbance 
was significantly different from lower-limb hyperreflexia or any less common characteristic 
(27.27% - 10.39% > 16.37%).  
 Upper extremity spasticity and hyperreflexia were identified as diagnostic criteria in 
15.58% and 14.29% of papers, respectively.  Lower extremity spasticity and hyperreflexia, 
which appeared in 8 (10.39%) and 7 (9.09%) papers, respectively, were not described as 
frequently as identical findings in the upper extremities.  Pathologically increased reflexes were 
noted in a minority of studies: Hoffman’s sign (6.49%) and Babinski’s sign (5.19%).  Eleven 
different signs or symptoms were found to be reported as diagnostic criteria with a frequency 
between 1.30% and 9.09%.  
Discussion 
 CSM remains a poorly defined clinical entity due, in large part, to the widely varying 
diagnostic criteria employed by practitioners.  As a result, it is difficult to make meaningful 
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comparisons between data sets, particularly when attempting to define indications for surgery, 
outcomes, and improvement or decline in functional status.As demonstrated in this review, the 
diagnosis of CSM should not be regarded as solely a disease of the elderly.  Numerous studies 
are cited in the literature, as in our search which found 7510 patients across 77 papers.  The 
present study also highlights the inconsistencies within the existing literature and identifies signs 
and symptoms commonly attributed to CSM.    
Long-tract Signs  
Long tract signs, such as, upper and lower extremity spasticity and hyperreflexia, serve as 
evidence of a disease process arising in the upper motor neurons of the corticospinal, 
spinothalamic, and posterior column tracts.  In patients with CSM, degenerative changes in the 
cervical spine result in compression of the spinal cord and resultant upper motor neuron 
dysfunction.  As a result, long-tract signs are generally regarded as hallmarks of CSM.[11-14]  In 
the present study, however, only a relatively small number of articles cited these findings. Signs 
consistent with pathologically increased reflexes, such as Hoffman’s (5.38%) and Babinski’s 
(4.30%) signs, were also noted in only a small percentage of studies.  
The relatively low frequency with which these findings were included among the 
diagnostic criteria was perhaps the most striking evidence of the poorly defined parameters.  
Most often, evidence of CSM on MRI was the major inclusion criteria, in place of long tract 
findings on examination.  Still, findings on MRI  were not standardized across studies, with 
broadly generalized spondylosis and cord compression being the most routinely found 
description. Other potential explanations for the disparities, include, improper diagnosis of a 
subset of patients or the inclusion of patients with varying degrees of disease progression under 
an all-encompassing term of CSM.  However, we chose a younger age group to limit the 
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variability in disease progression than occurs in later adulthood. In either case, the comparison of 
data between studies is rendered inadequate.   
The differential diagnosis for a patient presenting with myelopathy is broad and includes, 
inflammatory, infectious, vascular, traumatic, degenerative, toxic/metabolic, and neoplastic 
processes.[15]  Few papers in our series attempted to pursue diagnostic testing beyond imaging 
to establish a diagnosis of CSM, thereby raising the question of misdiagnosis.    When evaluated 
in the context of the widely varying diagnostic criteria described above, the diagnostic accuracy 
is considered even more suspect.  Patients with true CSM presenting without hyperreflexia or 
spasticity on exam are most likely presenting earlier in their disease course.  Inclusion of these 
patients with those more profoundly affected skews data interpretation, as the natural history of 
CSM is variable and difficult to predict.[16-18]  
Symptoms 
Gait disturbance (28.57%) and loss of sensation in the upper extremities (27.27%) were 
the most commonly identified presenting symptoms.  However, they were noted in less than a 
third of the articles reviewed and there was no significant difference between the frequency of 
their reporting and several other commonly cited neurologic findings. Additionally, eleven 
different signs or symptoms were found to be reported as diagnostic criteria with a frequency 
between 1.30% and 9.09%.  These results highlight the variability in diagnostic criteria between 
studies and the broad range of findings utilized by various authors in making the diagnosis of 
CSM.   
Multiple scores, including, the Nurick-score, modified Japanese orthopaedic association 
score (mJOA score), Cooper myelopathy scale (CMS), Prolo-score, and European myelopathy 
score (EMS) have been developed in an attempt to standardize the diagnosis of CSM.[19-24]  
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These scores are commonly referenced in the literature and are most extensively used in the 
research setting.  They are rarely employed in clinical practice and their utility is limited by the 
fact that they are largely based on the ability of patients to participate in activities of daily 
living.[2]  As a result, they do not reflect objective criteria on neurologic examination, results are 
inherently “user” dependent, and meaningful interpretation across studies is limited.  In our 
analysis, we found the majority of papers to report the JOA score, which is calculated from 
answers provided by patients on a questionnaire pertaining to their neurologic function.  
Obviously, this scoring system relies heavily on the interpretation of symptoms by an individual 
patient and lacks stringent criteria when attempting to define diagnostic criteria or outcomes.  
Nikaido et al. highlighted these inconsistencies in a prospective analysis of 87 patients who had 
undergone surgical treatment of CSM.[21]  The authors reported a lack of improvement in upper 
extremity function on JOA scores despite the fact that improved function was clearly observed 
on objective testing.   
The present study is limited by its retrospective design and the broad spectrum of study 
types from which data was pooled.  As mentioned above, the majority of studies did not pursue 
advanced diagnostic testing to establish a true diagnosis of CSM.  Thus, there is significant 
suspicion of inclusion of patients without CSM.  Also, due to the very nature and goals of the 
study, the inconsistencies inherent in the papers limit analysis of the data.  Nevertheless, we have 
effectively demonstrated the need for specific standards for reporting in CSM, given its high 
prevalence as a surgical disease.  Furthermore, the data emphasizes the need for prospective 
analysis of patients presenting with symptomatology consistent with CSM and highlights the 
shortcomings of existing patient-centered clinical scales.  Recent prospective studies in the past 
five years have been published that specify strict radiographic criteria for defining spondylotic 
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disease.  However, standards should be adopted to make for accurate comparison, as these 
radiographic criteria vary between studies, as well as the clinical criteria. 
Surgical decompression has been shown in previous studies to limit disease-progression 
and improve myelopathy [25-32].  However, a specific subgroup analysis comparing earlier 
onset CSM as defined by our age range 18-44 and their respective surgical outcomes is lacking.  
The authors were able to identify the frequency of this disease where possible in the literature, 
however, due to the lack of a common myelopathy grading scheme (JOA, mJOA, Nurick, 
Oswestry) and unifying age group, conclusions on surgical outcome are restricted to that of prior 
studies.   
Conclusion 
The literature demonstrates a wide range of neurologic signs and symptoms that are employed to 
make the diagnosis of CSM, with the majority of studies failing to employ stringent diagnostic 
criteria.  The clinician should not discount CSM as an explanation for the aforementioned 
findings, as it is is well-reported in the literature among the ages 18-44.  
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Table Legend 
Table 1. Incidence of individual signs/ symptoms found in reviewed papers.  Gait 
disturbance, which was identified in 28.57% of papers, was the most commonly cited sign or 
symptom.  Eleven different signs and symptoms were reported with a frequency between 1.30 
and 9.09%.   Data was analyzed by Cochran’s Q test and the critical range was 16.37%. 
Sign/ Symptom 
Upper/ Lower Extremity 
Involvement 
Number of 
Papers 
Percentage of 
Papers 
Gait disturbance   22 28.57% 
Pattern of loss of sensation 
(paresthesia/sensory disturbance) UL 21 
27.27% 
Clumsy hands   15 19.48% 
Spasticity UL 12 15.58% 
Pattern of loss of sensation 
(paresthesia/sensory disturbance) LL 12 
15.58% 
Hyperreflexia UL 11 14.29% 
Pattern of weakness UL 11 14.29% 
Pattern of weakness LL 9 11.69% 
Hyperreflexia LL 8 10.39% 
Spasticity LL 7 9.09% 
Bowel/bladder dysfunction   7 9.09% 
Lack of coordination   6 7.79% 
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Paresis UL 6 7.79% 
Paresis LL 5 6.49% 
Hoffman's Sign   5 6.49% 
Babinski's Sign   4 5.19% 
Lhermitte's Sign   2 2.60% 
Romberg's Sign   2 2.60% 
Hyporeflexia UL 1 1.30% 
Hyporeflexia LL 1 1.30% 
 
Figure Legend 
Figure 1. MRI, sagittal T2-weighted imaging of the cervical spine demonstrating pronounced 
focal cervical stenosis between C3 and C6. Hyperintensity of the cervical spinal cord is seen, 
most pronounced at C4. 
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Figure 2. MRI, axial T2-weighted imaging of the cervical spine at the level of C4-C5 showing a 
circumferential absence of cerebrospinal fluid signal.  
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Figure 3-4.CT, sagittal and corresponding C4-C5 axial views of the cervical spine showing 
minimal to moderate degenerative spondylosis of the neck.  
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